NuCana PLC ADR (NCNA)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

3 LOCHSIDE WAY EDINBURGH, UNITED KINGDOM EH12 9DT

NuCana plc operates as a biotechnology company. The Company develops anti-cancer medicines for ovarian, biliary, pancreatic, colorectal, haematology, oncology, and breast cancers. NuCana produces oncology medicines using a proprietary technology platform for cancer patients. NuCana serves customers in the United Kingdom and the United States.

Data based on most recent fiscal year report
Market Cap673.418 Million Shares Outstanding31.81 Million Avg Volume77.544 Thousand
1-Yr BETA vs S&P TR0.627 Current Ratio32.21 Quick Ratio32.21
View SEC Filings from NCNA instead.
Q2 2019 All Institutions Hedge Funds 1
To trade NCNA now:
Filers who had this stock in their top 10: 1 0 (0.0%)
13F Filers holding this stock: 24 3 (0.31%)
Aggregate 13F shares on 06/30/2019: 11.636 Million 785.735 Thousand
Aggregate 13F shares on 03/31/2019: 12.252 Million 659.294 Thousand
Percent change: -5.03% 19.18%
Funds creating new positions: 4
Funds Adding to an existing position: 6 2
Funds closing out their position: 3
Funds reducing their position: 6 1
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding NCNA (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments